At a glance
- Originator GlaxoSmithKline
- Class Antihypertensives
- Mechanism of Action Dopamine D1 receptor agonists; Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 17 Oct 2001 Discontinued-unspecified phase for Hypertension